Universität zu Köln

Klein, Jan M., Henke, Alexander, Sauer, Maike, Bessler, Martina, Reiners, Katrin S., Engert, Andreas, Hansen, Hinrich P. and von Strandmann, Elke Pogge (2013). The Histone Deacetylase Inhibitor LBH589 (Panobinostat) Modulates the Crosstalk of Lymphocytes with Hodgkin Lymphoma Cell Lines. PLoS One, 8 (11). SAN FRANCISCO: PUBLIC LIBRARY SCIENCE. ISSN 1932-6203

Rothe, Achim, Jachimowicz, Ron D., Borchmann, Sven, Madlener, Marie, Kessler, Joerg, Reiners, Katrin S., Sauer, Maike, Hansen, Hinrich P., Ullrich, Roland T., Chatterjee, Sampurna, Borchmann, Peter, Yazaki, Paul, Koslowsky, Thomas C., Engert, Andreas, Heukamp, Lukas C., Hallek, Michael and von Strandmann, Elke Pogge (2014). The bispecific immunoligand ULBP2-aCEA redirects natural killer cells to tumor cells and reveals potent anti-tumor activity against colon carcinoma. Int. J. Cancer, 134 (12). S. 2829 - 2841. HOBOKEN: WILEY. ISSN 1097-0215

Sauer, Maike (2015). Natural killer cell-mediated tumor immunosurveillance: Molecular mechanisms directing the expression of ligands for NKG2D. Thesis Abstract, Universität zu Köln.

Sauer, Maike, Reiners, Katrin S., Hansen, Hinrich P., Engert, Andreas, Gasser, Stephan ORCID: 0000-0002-5616-0914 and von Strandmann, Elke Pogge (2013). Induction of the DNA damage response by IAP inhibition triggers natural immunity via upregulation of NKG2D ligands in Hodgkin lymphoma in vitro. Biol. Chem., 394 (10). S. 1325 - 1332. BERLIN: WALTER DE GRUYTER GMBH. ISSN 1437-4315

Shatnyeva, Olga M., Hansen, Hinrich P., Reiners, Katrin S., Sauer, Maike, Vyas, Maulik ORCID: 0000-0003-2996-4682 and von Strandmann, Elke Pogge (2015). DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies. Front. Genet., 6. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-8021

Shatnyeva, Olga M., Hansen, Hinrich P., Reiners, Katrin S., Sauer, Maike, Vyas, Maulik ORCID: 0000-0003-2996-4682 and von Strandmann, Elke Pogge (2015). DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies. Front. Genet., 6. LAUSANNE: FRONTIERS MEDIA SA. ISSN 1664-8021